baber/WOPTO huggingface dataset:
Patent NZ-503080-A (NZ)
Title: Apparatus for producing coreless rolls of sheet material by winding outer layer at higher tension than inner layer
Inventor: SALZSAULER DONALD J
IPC: B65H18/28
Filed: 1998-02-10
Abstract: A roll (50) of sheet material, such as plastic film wrap, having an inner layer wound at low tension and an outer layer wound under greater tension provides a coreless roll. Eliminating the need for a core reduces the cost of producing rolls of sheet material, and reduces the weight and outer dimensions of the roll with a consequent reduction in shipping and storage costs. An apparatus (10) and method for producing such a roll (50), from a pre-wound master roll (20) or as part of a production line for forming the sheet material, involves varying the longitudinal tension applied to the sheet material (22) as it is wound onto an expandable mandrel (100). After the roll (50) has cured, the mandrel (100) is collapsed and disengaged from the roll (50) to provide a coreless roll (50). The master roll (20) can be pre-stretched prior to forming the coreless roll (50), if desired, and can be pre-stretched as a step in the formation of the coreless roll (50).
Patent NZ-507156-A (NZ)
Title: Method of producing a thickened slimes fraction blended with a tailings fraction
Inventor: MJACU NCEBA AUBREY
IPC: B09B1/00
Filed: 1999-03-19
Abstract: Described is a method for producing a thickened slimes fraction blended with a tailings fraction for delivery to a discharge or disposal point, the method comprising the steps of: i) Providing a thickened slimes fraction; ii) Providing a tailings fraction; iii) Forming a bed of the tailings fraction on a de-watering screen; iv) Delivering the thickened slimes fraction onto the bed of tailings fraction; and v) Allowing the slimes fraction to de-water through the bed and the screen.
Patent NZ-512429-A (NZ)
Title: Crystals of 5-[ {6-(2-fluorobenzyl)oxy-2-naphthyl} methyl]-2,4-thiazolidinedione
Inventor: OE TAKAYUKI
IPC: A61P3/10
Filed: 1999-11-19
Abstract: Crystals of 5-[{6-(2-fluorobenzyl)oxy-2- naphthyl}methyl]-2,4-thiazolidinedione characterised by: Type A, at least one peak in a powder X-ray diffraction pattern (2 theta) of 11.5, 17.0, 17.7, 22.4, and 25.7, and/or a sharp endothermic band at 152°C, from differential scanning calorimetry analysis. Type B, at least one peak in a powder X-ray diffraction pattern (2 theta) of 10.5, 18.4, 20.9, 23.0, 26.7, and 29.2, and/or a sharp endothermic band at 128°C, from differential scanning calorimetry analysis. Type C, at least one peak in a powder X-ray diffraction pattern (2 theta) of 12.5, 14.5, 17.6, 18.8, 22.1, 25.9, 26.6 and 28.3, and/or a sharp endothermic band at 146°C, from differential scanning calorimetry analysis. Type D, at least one peak in a powder X-ray diffraction pattern (2 theta) of 10.7, 14.5, 15.1,15.8, 17.4, 18.5, 20.5, 22.2, 25.3, 26.8, and 27.8, and/or a sharp endothermic band at 147°C, from differential scanning calorimetry analysis. The crystals are used in the manufacture of medicaments for the treatment of diabetes, hyperlipidemia, hyperuricemia, leukemia, or pancreatitis.
Patent NZ-513363-A (NZ)
Title: High solids acid etch resistant clear coating composition
Inventor: UHLIANUK PETER WILLIAM
IPC: C09D201/10
Filed: 2000-03-16
Abstract: Described  is  a clear coating composition  comprising isocyanate, silane and melamine components.  The  isocyanate component  comprises an aliphatic polyisocyanate  having  on average 2 to 6 isocyanante functionalities.
Patent NZ-517646-A (NZ)
Title: Sustained release formulation of a somatostatin analog with a polymer attached
Inventor: MOREAU JACQUES-PIERRE
IPC: A61K47/48
Filed: 2000-08-16
Abstract: Compound (I) comprises compound (A) and a polymer. The amino group of compound (A) is ionically bonded to the carboxylic group of the acid units of the polymer. The polymer comprises lactide units, glycolide units and tartaric acid unit. The ratio in the polymer: of the lactide units is from and including about 71% to about 73%, of the glycolide units is from and including about 26% to about 28%; and of the tartaric acid units is from and including about 1% to about 3%. Preferably compound(I) is in the form of microparticles. Compound (I) is useful for the treatment of systemic sclerosis, pancreatic pseudocysts, pancreatic ascites, ViPoma, nesidoblastosis, hyperinsulinism, gastrinoma, Zollinger-Ellison Syndrome, hypersecretory diarrhea, scleroderma, irritable bowel syndrome, upper gastrointestinal bleeding, postprandial portal venous hypertension, complications of portal hypertension, small bowel obstruction, duodenogastric reflux, Cushing's Syndrome, gonadotropinoma, hyperparathyroidism, diabetic neuropathy, macular degeneration, hypocalcemia of malignancy, Paget's disease, meningioma, cancer cachexia, psoriasis, hypotension and panic attacks.
Patent NZ-517958-A (NZ)
Title: Process for the conditioning of polluted water comprising treating with hydrogen peroxide and/or ozone and a Fe(O)OH catalyst
Inventor: HEMPEL DIETMAR C
IPC: C01G49/02
Filed: 2002-03-22
Abstract: Disclosed is a process for the treating or conditioning of polluted water using a source of hydrogen peroxide and/or ozone and a heterogeneous catalyst containing Fe(O)OH structural elements. In particular, the polluted water is effluent or sewerage.
Patent NZ-520745-A (NZ)
Title: Signaling aptamers that transduce molecular recognition to a differential signal
Inventor: ELLINGTON ANDREW
IPC: C12Q1/6816
Filed: 2001-02-02
Abstract: A method of tranducing the conformational change of a signaling aptamer that occurs upon the signaling aptamer binding a ligand to a differential optical signal generated by a reporter molecule comprises the steps of: covalently coupling the reporter molecule to an aptamer to form the signaling aptamer wherein the reporter molecule replaces a nucleic acid residue in the aptamer or is inserted between two nucleic acid residues in the aptamer such that the placement does not interfere with the ligand-binding site of the aptamer; contacting the signaling aptamer with the ligand under conditions whereby the signaling aptamer binds the ligand; and detecting the differential optical signal generated by the reporter molecule transduced by the conformational change in the signaling aptamer upon binding the ligand. Preferably the optical signal is selected from fluorescence, colorimetric intensity, anisotropy, polarization, lifetime emission wavelength and excitation wavelength and the reporter molecule is a fluorescent dye.
Patent NZ-523695-A (NZ)
Title: Water-soluble polysaccharide preparations for pharmaceutical compositions and dietary supplements as immunotherapeutic compositions
Inventor: PASCO DAVID STANLEY
IPC: C07H1/08
Filed: 2001-07-10
Abstract: Immunostimulatory polysaccharides can be preferentially extracted from food-grade microalgae using an aqueous ethanol extraction procedure. The resulting preparations exhibit extremely potent immunostimulatory activity. The preferential extraction of these immunostimulatory polysaccharides is dependent on the concentration of ethanol used and the extraction temperature. The most efficient conditions are 50% ethanol concentration at temperatures between 60 DEG and 70 DEG C. The isolated polysaccharide preparation are potentially useful as a botanical or pharmaceutical preparation to improve immune function.
Patent NZ-524623-A (NZ)
Title: A seal and a pipe system allowing for misalignment
Inventor: SHANNON ROD
IPC: F16L21/035
Filed: 2001-08-15
Abstract: Seal (1) for sealing a male section to a female section of pipe has its base (2) fitted in channel (25) in one of the sections. On axial overlapping of the pipe sections, radially more protuberant first sealing portion (5) is compressed inwardly, which, due to the interconnection of portion (5) with second portion (6), also urges it into sealing engagement. Also disclosed is a pipe system where one of male pipe section (51) and female pipe section (53) carries groove (60) allowing limited angular misalignment of section (51, 53) when overlapping. Groove (60) is preferably provided in male section (51) and further groove (61) is also provided therein to receive, for example, seal (1).
Patent NZ-525483-A (NZ)
Title: Providing object properties using static methods for property attachment from other classes
Inventor: BOGDAN JEFFREY L
IPC: G06F9/44
Filed: 2003-04-24
Abstract: A computer-readable medium including an object with a property in a first set of properties includes a data structure including definitions for each of a second set of properties, and at least one static method. The static method is associated with one property in the second set of properties and includes a first parameter, which uniquely identifies the one property. The static method is operative to associate the property with the object without specifying an explicit reference to the one property in the object.
Patent NZ-526847-A (NZ)
Title: Compositions of estrogen-cyclodextrin complexes
Inventor: BACKENSFELD THOMAS
IPC: A61P15/18
Filed: 2001-12-20
Abstract: Pharmaceutical compositions comprising low doses of sensitive complexes between an estrogen and a cyclodextrin are provided with improved stability are disclosed. In specific embodiments the composition comprises a complex between ethinyl estradiol and beta-cyclodextrin in a granulate preparation. The improved stability was achieved by the provision of compositions essentially free of polyvinylpyrrolidone, since this excipient was found to degrade ethinyl estradiol. Furthermore, a method for improving the stability of an estrogen in a composition and for manufacturing such a stable composition is provided. Essentially, the granulate preparation are manufactured under careful control of the relative humidity.
Patent NZ-527053-A (NZ)
Title: Modified amyloid precursor protein polynucleotides and polypeptides
Inventor: GURNEY MARK E
IPC: C12N5/06
Filed: 1999-09-23
Abstract: A polypeptide comprising the amino acid sequence of a mammalian amyloid protein precursor (APP) or fragment thereof containing an APP cleavage site recognizable by a mammalian beta-secretase, and further comprising two lysine residues at the carboxyl terminus of the amino acid sequence of the APP. (62) Divided out of 510708
Patent NZ-527474-A (NZ)
Title: Fungicide mixtures
Inventor: PTOCK ARNE
IPC: A01N43/80
Filed: 2002-01-19
Abstract: A fungicidal mixture comprising the imidazole derivative of formula Ia and valinamides of formula II in which R' is phenyl which is substituted in the 4-position by halogen or C1-C4-alkyl or C1-C4-alkoxyl, or is 1- or 2-naphthyl, or is benzothiazol-2-yl which is substituted in the 6-position by halogen; and R" is C3-C4-alkyl in a synergistically effective amount.
Patent NZ-531406-A (NZ)
Title: Plaster for the treatment of dysfunctions and disorders of nail growth
Inventor: SUSILO RUDY
IPC: A61K47/32
Filed: 2002-09-04
Abstract: Disclosed is the use of a contact layer designed to be in close contact with the nail and optionally with the surrounding skin, said contact layer comprising: a) an adhesive; b) at least one skin and/or nail permeation enhancer; c) at least one therapeutically effective amount of a pharmaceutically active agent contained in said contact layer; and d) at least one additive selected from the group consisting of binders, cross linkers, softeners, solvents, fillers, and antioxidants, and mixtures thereof; for the manufacture of a plaster for the transdermal and/or transnail prophylaxis or treatment of onychodystrophy, except onychomycosis, wherein the pharmaceutically active agent is not sertaconazole.
Patent NZ-534706-A (NZ)
Title: Electrically powered and monitored lock
Inventor: GRANVILLE JAMES MALCOLM
Filed: 2004-08-12
Abstract: An electrically powered and monitored lock assembly (1) is disclosed. The lock has sensors for monitoring the condition of; the latch bolt (19) (extended or retracted); the latch bolt actuator (12) (actuating or not actuating); a locking bar (8) (blocking or non-blocking of the actuator); and the door (open or closed). Each condition is sensed and has its status depicted separately. An overall status of the lock, based on the sensed conditions, can also be depicted. The status depiction can be displayed either locally or at a remote location.
Patent NZ-535843-A (NZ)
Title: Use of carbon-2-modified-19-nor-vitamin D analogs to induce the formation of new bone
Inventor: DELUCA HECTOR F
IPC: A61P1/02
Filed: 2003-03-12
Abstract: Use of 2-carbon-modified derivatives of 1alpha,25-dihydroxyvitamin D3 of formula (I) to stimulate osteoblast cells to form new bone is disclosed. The ability of the 2-carbon-modified vitamin D analogs to stimulate new bone formation suggests that these compounds can be used where synthesis of new bone is required. Thus, these compounds can be used either systemically or locally to stimulate the growth of bone transplants, to increase the rate of fracture healing and thereby reduce the time required for the healing of fractures, the stimulation of bone growth when required for replacement surgery, and also for the growth of bone to implants or other devices required to maintain the skeleton or teeth in the proper positions.
Patent NZ-540297-A (NZ)
Title: Anhydrous crystalline azido cytosine hemisulfate derivative
Inventor: CONNOLLY TERRENCE JOSEPH
IPC: A61K31/7072
Filed: 2003-12-08
Abstract: A hemisulfate salt of 1-[4(S)-azido-2(S),3(R)-dihydroxy-4-(hydroxymethyl)-1(R)-cyclopentyl]cytosine (Ia) with improved stability and physical properties which facilitate manufacturing, handling and formulating the compound and polymorphic crystalline forms thereof are disclosed. These compounds are suitable for treating a disease mediated by the Hepatitis C Virus.
Patent NZ-540490-A (NZ)
Title: Water-soluble polymer alkanal conjugates with human growth hormone
Inventor: KOZLOWSKI ANTONI
IPC: A61K47/48
Filed: 2003-09-09
Abstract: Disclosed is a compound having the structure of formula (I), wherein hGH represents a residue of human growth hormone comprising an N-terminal amino acid; and wherein each mPEG represents a methoxy-polyethylene glycol group having a molecular mass between about 18000 to about 22000 daltons.
Patent NZ-540505-A (NZ)
Title: Morpholine derivatives for use as dopamine agonists in the treatment of I.A. sexual dysfunction
Inventor: ALLERTON CHARLOTTE MORIA NORFO
IPC: C07D413/04
Filed: 2003-12-02
Abstract: Morpholine derivatives of formula (I), (la) and (lb) and pharmaceutically acceptable salts and solvates thereof are disclosed, wherein: A is selected from C-X and N; B is selected from C-Y and N; R1 is selected from H and (C1-C6)alkyl; R2 is selected from H and (C1-C6)alkyl; X is selected from H, HO, C(O)NH2, NH2; Y is selected from H, HO, NH2, Br, Cl and F; Z is selected from H, HO, F, CONH2 and CN; with the provisos that: for a compound of formula (I), (la) or (lb), when A is C-X, B is C-Y, at least one of X, Y and Z must be OH; for a compound of formula (I), when A is C-X and B is C-Y, Y is H, Z is H, R1 is H and R2 is H, then X cannot be OH. These compounds are useful as dopamine agonists for the treatment sexual dysfunction selected from the conditions listed in the specification.
Patent NZ-541459-A (NZ)
Title: Viscous food and beverage dispensing system
Inventor: DAMIANO DOMINICK
IPC: B67D7/78
Filed: 2004-01-30
Abstract: A food or beverage delivery system comprising at least one disposable or recyclable package containing viscous food therein; a dispensing apparatus having a holder for holding the food package and a pressure-displacement device that forces the food out of the package; and a valve; wherein the food package comprises an outlet portion which is part of the package, and wherein the valve is adapted to act in closure on the outlet portion to cut off portions of food coming out of the package without the food contacting the apparatus. The system may deliver frozen confection more hygienically with or without flavourings. The frozen confection may be a layered product with flavouring forming separations, bottoms or toppings. It may also be used to more accurately dose viscous beverage concentrates in a beverage dispenser.
Patent NZ-548248-A (NZ)
Title: Box-shape container made from two container halves with the side walls of the first half having increasing height and the second decreasing height towards the front wall and with one free end of the front wall of the first container having a convex curvature
Inventor: D AMATO GIANFRANCO
Filed: 2006-06-30
Abstract: This discloses a box-shaped container made from two container halves, joined together for swivelling along a joining edge 48. Each half comprises a bottom wall 36 37, side walls 38 39 40 41 protruding away from them and front 42 43 and rear walls 44 45 joining them at their ends. The joining edge 48 is formed by the upper end edges of the rear walls 44 45, the side walls 38 39 of the first container half are formed with increasing height and the side walls 40 41 of the second container half are formed with decreasing height in the respective direction to the front wall 42 43. One free end edge 53 of the front wall of the first container half has a convex curvature.
Patent NZ-548833-A (NZ)
Title: Loquat kernel as a nematicide
Inventor: BAEKELMANS IVO
IPC: A01N65/18
Filed: 2005-02-07
Abstract: Provided is the use of loquat kernel to kill, inactivate or repel nematodes. Further provided are its use against plant parasitic nematodes, use of it in ground, chopped, freeze dried or spray dried form or in the form of an extract. Also provided is a nematicide comprising soluble components of loquat kernel.
Patent NZ-555033-A (NZ)
Title: Vertical Tool Rack Storage Device
Inventor: CHANWA NGUY
IPC: A47B73/00
Filed: 2005-10-26
Abstract: Disclosed is a vertical tool rack storage device which includes a hollow upright pivot shaft, a plurality of flat tool racks for holding tool bits and parts, and a plurality of connectors for pivotally coupling tool racks to the hollow upright pivot shaft for enabling the tool racks to be arranged in a stack and individually turnable about the hollow upright pivot shaft.
Patent NZ-555112-A (NZ)
Title: Spas and bathing systems with upgradeable and interchangeable jet stations
Inventor: LUDLOW DAVID J
IPC: A47K3/00
Filed: 2004-10-21
Abstract: A bathing system 101 comprising a shell 103 moulded to define a containment for containing water, a hollow moulded in the shell 103, at least one fluid connector in the hollow that is associated with a fluid supply system to supply fluid to the connector, a canister with a jet plate 111 with at least one jet 119 on the jet plate 111, the jet plate 111 dimensioned and constructed to fit over the hollow and constructed such that when the canister is in an installed position in the hollow, the at least one jet 119 is disposed to inject fluid into the containment, the canister having a fluid port and structure for fluid communication between the fluid port and the jet 119 or jets 119, the fluid port and the fluid connector disposed such that the fluid port registers with the fluid connector when the canister is in the installed position to provide a fluid supply from the fluid supply system, through the fluid connector and fluid port, to the at least one jet 119, the canister, hollow, the fluid connector and fluid port constructed such that the canister is reversibly removable from the hollow from the installed position.
Patent NZ-555128-A (NZ)
Title: Inductive power transfer pad and system
Inventor: COVIC GRANT ANTHONY
IPC: H02J7/00
Filed: 2007-05-10
Abstract: An inductive power transfer pad is disclosed which comprises: a coil having at least one turn of a conductor; one or more ferromagnetic slabs; and a shield member arranged around both the coil and the ferromagnetic slabs for channelling electromagnetic flux. When the inductive power transfer pad is in use, the coil is arranged in a plane substantially parallel to that of the ferromagnetic slabs.
Patent NZ-560615-A (NZ)
Title: Perfusion and/or preservation solution for organs
Inventor: YOUNG LINDON H
IPC: C12N5/071
Filed: 2006-01-13
Abstract: Provided is a solution when used for perfusion, preservation, and/or re-perfusion for organ preservation comprising at least one peptide inhibitor of protein kinase Cbetall (PKCbetall) , wherein said organ is a human organ external to and isolated from a human body or a nonhuman organ. The solution is useful for preserving human organs for transplantation.
Patent NZ-563263-A (NZ)
Title: Composition and methods for immunomodulation in an organism
Inventor: LEFRANCOIS LEO
IPC: C07K1/00
Filed: 2006-05-17
Abstract: Disclosed is the use of a composition comprising: (a) a purified interleukin-15 (lL-15) polypeptide and a purified soluble form of an interleukin-15 receptor alpha (IL-15Ra) polypeptide; (b) a purified chimeric polypeptide in which an IL-15 polypeptide is linked to a soluble form of an IL-15Ra polypeptide; (c) a purified IL-15 polypeptide and a purified chimeric polypeptide in which a soluble form of an IL-15Ra polypeptide is covalently linked to the Fc portion of an antibody; (d) a purified complex comprising an IL-15 polypeptide bound to a soluble form of an IL-15Ra polypeptide; or (e) a purified complex comprising an IL-15 polypeptide bound to a soluble form of an IL-15Ra polypeptide that is covalently linked to the Fc portion of an antibody; in the manufacture of a medicament for treating lymphopenia, an immune disorder, a hematopoietic disorder, cancer, AIDs or an infectious disease in a human. The treatment may be by way of gene therapy.
Patent NZ-567042-A (NZ)
Title: Processes and intermediates for the prepration of aliskiren
Inventor: SEDELMEIER GOTTFRIED
IPC: C07F1/02
Filed: 2006-10-16
Abstract: Disclosed are intermediates and processes for the preparation of pharmaceutical compounds such as aliskiren (as encompassed by formula (XII)), wherein compounds of formula (XII) can be prepared from the compounds of formula (IX), (VIII) or (II) by processes which comprise the step of reacting the compound of the formula (IX), with an amine of the formula (XIII) wherein the amido nitrogen can also be protected if desired and the protecting group then be removed in the corresponding protected compound of the formula XII, or a salt thereof; and wherein the substituents are as defined herein. Further disclosed are methods for preparing the compounds of formula (II), (VIII) and (IX).
Patent NZ-571511-A (NZ)
Title: New process for the synthesis of strontium ranelate and its hydrates
Inventor: VAYSSE-LUDOT LUCILE
IPC: C01F11/00
Filed: 2008-09-25
Abstract: Disclosed is a process for the synthesis of strontium ranelate of formula (I) and its hydrates, characterised in that the compound of formula (II) wherein R and RÆ, which may be the same or different, each represent a linear or branched (C1-C6)alkyl group, is reacted with sodium hydroxide or potassium hydroxide, in water or in a mixture of water and an organic solvent at a temperature from 0 to 100 degrees Celsius to yield the salt of formula (III) wherein A represents Na or K, which is reacted with strontium chloride, in a mixture of water and an organic solvent, at a temperature from 0 to 100 degrees Celsius to yield, after isolation, strontium ranelate or one of its hydrates.
Patent NZ-571556-A (NZ)
Title: Straddle carrier with automatic steering
Inventor: BAUER REINHARD
IPC: B66C13/48
Filed: 2008-09-26
Abstract: A straddle carrier for transporting and stacking freight containers, with automatic steering, is made up of two chassis beams having steerable wheels, for travelling over the container stack. At least one laser scanner measures the distance to a container wall from different angles, and passes the measurement signals to an electronic control, which calculates a steering angle reference value for the electronically regulated vehicle steering from the measurement signals.